Comparative Effect of Nebivolol vs. Metoprolol on Insulin Sensitivity and Fibrinolytic Balance in Metabolic Syndrome
Status:
Completed
Trial end date:
2011-06-01
Target enrollment:
Participant gender:
Summary
Test the hypothesis that nebivolol treatment improves fibrinolytic balance and insulin
sensitivity compared to metoprolol treatment in individuals with metabolic syndrome.
Phase:
Phase 4
Details
Lead Sponsor:
Vanderbilt University Vanderbilt University Medical Center